glp-1 shot vs pill semaglutide pills injections Pills vs. Injections: Will Oral Drugs Replace Pens? 3 Takeaways from the Landmark

2021 NEJM) showed 14.9% mean weight loss at 68 weeks for Wegovy

In the market, a large number of teams are developing therapeutic drugs targeting GLP-1R, GIPR, and GCGR

Pemvidutide is another dual agonist of GLP-1R and GCGR that is currently under clinical investigation

A clinician may lower a dose when side effects are getting in the way of normal life, then watch to see whether appetite control remains good enough

It is not FDA-approved for weight loss, but is often prescribed off-label by licensed providers to support appetite regulation, food craving reduction, and weight management

doi: 10.1097/XCE.0000000000000181 [DOI] [PMC free article] [PubMed] [Google Scholar] 7